Vancouver, British Columbia–(Newsfile Corp. – April 15, 2024) – ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of immuno-oncology, is pleased to announce that the Company’s management will be ringing the opening bell for the Canadian Securities Exchange on Wednesday April 17, 2024, and invites its shareholders to tune in at 930am EST to participate in the celebration.
“We are honoured to be ringing the opening bell of the CSE. It marks the next stage of growth for ME Therapeutics as we advance and progress towards the discovery and development of potential new drug candidates aimed at harnessing the immune system to fight cancer. We are proud to not only grow our corporate profile for both current and new investors but also to be leaders and innovators in a space with the potential to fight against cancers which currently are either…
